Evotec (EVO) News Today → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free EVO Stock Alerts $4.83 +0.06 (+1.26%) (As of 03:36 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 2:45 PM | marketbeat.comEvotec (NASDAQ:EVO) Sees Large Volume IncreaseEvotec (NASDAQ:EVO) Sees Strong Trading VolumeMay 28 at 1:18 AM | americanbankingnews.comQ2 2024 EPS Estimates for Evotec SE (NASDAQ:EVO) Boosted by HC WainwrightMay 27 at 1:24 AM | marketbeat.comEvotec SE (NASDAQ:EVO) to Post Q2 2024 Earnings of ($0.01) Per Share, HC Wainwright ForecastsEvotec SE (NASDAQ:EVO - Free Report) - Equities research analysts at HC Wainwright boosted their Q2 2024 EPS estimates for Evotec in a report released on Thursday, May 23rd. HC Wainwright analyst D. Tsao now anticipates that the company will earn ($0.01) per share for the quarter, up from their pMay 26 at 1:36 AM | americanbankingnews.comEvotec (NASDAQ:EVO) Hits New 52-Week Low at $4.77May 25 at 7:32 AM | americanbankingnews.comEvotec (NASDAQ:EVO) Shares Gap Down to $5.17May 24, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Sets New 52-Week Low at $4.77Evotec (NASDAQ:EVO) Sets New 12-Month Low at $4.77May 24, 2024 | americanbankingnews.comEvotec's (EVO) "Buy" Rating Reaffirmed at HC WainwrightMay 23, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS) and Evotec AG (EVO)May 23, 2024 | msn.comEvotec SE (NASDAQ:EVO) Q1 2024 Earnings Call TranscriptMay 23, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for Evotec (NASDAQ:EVO)HC Wainwright reiterated a "buy" rating and set a $11.00 price objective on shares of Evotec in a report on Thursday.May 22, 2024 | msn.comEvotec to exit gene therapy business, close Austria siteMay 22, 2024 | seekingalpha.comEvotec SE 2024 Q1 - Results - Earnings Call PresentationMay 22, 2024 | finance.yahoo.comGerman drug discovery company Evotec reports loss in 'challenging' Q1May 22, 2024 | investorplace.comEVO Stock Earnings: Evotec Beats EPS, Beats Revenue for Q1 2024May 22, 2024 | markets.businessinsider.comEQS-News: Evotec reports Q1 2024 results and provides corporate updateMay 22, 2024 | finance.yahoo.comEvotec Reports Q1 2024 Results and Provides Corporate UpdateMay 20, 2024 | americanbankingnews.comEvotec (EVO) Scheduled to Post Quarterly Earnings on WednesdayMay 19, 2024 | americanbankingnews.comEvotec (NASDAQ:EVO) Shares Gap Down to $5.49May 16, 2024 | marketbeat.comEvotec (EVO) Set to Announce Earnings on WednesdayEvotec (NASDAQ:EVO) will be releasing earnings before the market opens on Wednesday, May 22, Zacks reports.May 14, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Sees Strong Trading VolumeEvotec (NASDAQ:EVO) Sees Strong Trading VolumeMay 11, 2024 | marketbeat.comShort Interest in Evotec SE (NASDAQ:EVO) Increases By 186.3%Evotec SE (NASDAQ:EVO - Get Free Report) was the target of a large increase in short interest in April. As of April 30th, there was short interest totalling 169,500 shares, an increase of 186.3% from the April 15th total of 59,200 shares. Based on an average daily trading volume, of 109,200 shares, the short-interest ratio is currently 1.6 days. Approximately 0.1% of the company's shares are sold short.May 2, 2024 | investorplace.com3 Growth Stocks to Buy at 52-Week LowsApril 30, 2024 | markets.businessinsider.comEQS-News: Bayer and Evotec collaborate to advance precision cardiologyApril 29, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Shares Gap Up to $5.02Evotec (NASDAQ:EVO) Shares Gap Up to $5.02April 29, 2024 | msn.comCompare with Evotec SE (EVT)April 26, 2024 | marketbeat.comBrokers Offer Predictions for Evotec SE's Q1 2024 Earnings (NASDAQ:EVO)Evotec SE (NASDAQ:EVO - Free Report) - Equities researchers at HC Wainwright issued their Q1 2024 earnings per share (EPS) estimates for Evotec in a note issued to investors on Thursday, April 25th. HC Wainwright analyst D. Tsao anticipates that the company will earn ($0.03) per share for the quaApril 26, 2024 | finance.yahoo.comEvotec SE (ETR:EVT) Yearly Results: Here's What Analysts Are Forecasting For This YearApril 25, 2024 | marketbeat.comHC Wainwright Trims Evotec (NASDAQ:EVO) Target Price to $11.00HC Wainwright reduced their price target on shares of Evotec from $14.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday.April 25, 2024 | finance.yahoo.comEvotec Full Year 2023 Earnings: EPS Misses ExpectationsApril 24, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Reaches New 12-Month Low at $5.10Evotec (NASDAQ:EVO) Hits New 52-Week Low at $5.10April 24, 2024 | seekingalpha.comEvotec: Still A Speculative Buy After A Significant DeclineApril 24, 2024 | finance.yahoo.comLife Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual ForecastApril 24, 2024 | seekingalpha.comEvotec SE 2023 Q4 - Results - Earnings Call PresentationApril 24, 2024 | investorplace.comWhy Is Evotec (EVO) Stock Down 33% Today?April 24, 2024 | investorplace.comWhy Is Evotec (EVO) Stock Down 33% Today?April 24, 2024 | marketwatch.comEvotec Shares Tumble After Company Books Significantly Lower EarningsApril 24, 2024 | msn.comTesla Surges 12% with 2025 Affordable Vehicle Promise, Evotec Slumps 36% on Uncertain Outlook, and Latest EarningsApril 24, 2024 | msn.comGerman drug maker Evotec sees increase in annual revenueApril 24, 2024 | markets.businessinsider.comEvotec Appoints Christian Wojczewski As CEOApril 24, 2024 | msn.comEvotec SE reports FY results; initiates FY24 outlookApril 23, 2024 | markets.businessinsider.comEQS-Adhoc: Evotec SE appoints Dr Christian Wojczewski as Chief Executive OfficerApril 22, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Shares Gap Up to $7.07Evotec (NASDAQ:EVO) Shares Gap Up to $7.07April 19, 2024 | investing.comEvotec and Variant Bio partner to develop fibrosis treatmentsApril 18, 2024 | prnewswire.comEVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTSApril 17, 2024 | msn.comCompare with DAXsubsector All Industrial Machinery Index (4N67)April 15, 2024 | finance.yahoo.comEvoTec Power Set to Showcase Innovative Alternator Solutions at Middle East Energy 2024April 12, 2024 | msn.comEurope's STOXX 600 flat on rising Middle East tensions, energy stocks spikeApril 12, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Trading 4.2% Higher Evotec (NASDAQ:EVO) Trading Up 4.2%April 12, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Stock Rating Upgraded by Deutsche Bank AktiengesellschaftDeutsche Bank Aktiengesellschaft raised shares of Evotec from a "hold" rating to a "buy" rating in a report on Friday.April 11, 2024 | ft.comDrugmakers race to find alternative suppliers as US cracks down on Chinese biotech Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. EVO Media Mentions By Week EVO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVO News Sentiment▼0.470.92▲Average Medical News Sentiment EVO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVO Articles This Week▼223▲EVO Articles Average Week Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ardelyx News Keros Therapeutics News Syndax Pharmaceuticals News NewAmsterdam Pharma News Protagonist Therapeutics News Galapagos News Kura Oncology News Agios Pharmaceuticals News Harmony Biosciences News Edgewise Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVO) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe 7th Trillion Dollar Company?The Oxford ClubThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarElon to Transform U.S. Economy? Porter & Company[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsIs Artificial Intelligence the Biggest Bubble in History?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
